×
About 4,630 results

ALLMedicine™ Epistaxis Center

Research & Reviews  1,407 results

Angina Bullosa Hemorrhagica
https://emedicine.medscape.com/article/1078960-overview

Aug 11th, 2022 - Practice Essentials Angina bullosa hemorrhagica (ABH) is the term used to describe acute, benign, and generally subepithelial oral mucosal blisters filled with blood that are not attributable to a systemic disorder or hemostatic defect. [1, 2, 3, ...

Angina Bullosa Hemorrhagica
http://emedicine.medscape.com/article/1078960-overview

Aug 11th, 2022 - Practice Essentials Angina bullosa hemorrhagica (ABH) is the term used to describe acute, benign, and generally subepithelial oral mucosal blisters filled with blood that are not attributable to a systemic disorder or hemostatic defect. [1, 2, 3, ...

Angina Bullosa Hemorrhagica
https://emedicine.medscape.com/article/1078960-print

Aug 11th, 2022 - Practice Essentials Angina bullosa hemorrhagica (ABH) is the term used to describe acute, benign, and generally subepithelial oral mucosal blisters filled with blood that are not attributable to a systemic disorder or hemostatic defect.[1, 2, 3, 4...

European Reference Network for Rare Vascular Diseases (VASCERN): When and how to use in...
https://doi.org/10.1016/j.ejmg.2022.104575
European Journal of Medical Genetics; Dupuis-Girod S, Shovlin CL et. al.

Aug 9th, 2022 - Hereditary haemorrhagic telangiectasia (HHT) is a rare vascular multisystemic disease that leads to epistaxis, anaemia due to blood loss, and arteriovenous malformations (AVMs) in organs such as the lungs, liver and brain. HHT prevalence is estima...

The Use of Beta-Blockers in Hereditary Hemorrhagic Telangiectasia-Related Epistaxis: A ...
https://doi.org/10.1177/19458924221118131
American Journal of Rhinology & Allergy; Albarki H, Rimmer J

Aug 6th, 2022 - Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disease affecting 1 in 5000 individuals. Epistaxis is seen in more than 90% of patients with HHT. Severe recurrent epistaxis can significantly decrease quality of life and may be...

see more →

Guidelines  1 results

Clinical Practice Guideline: Nosebleed (Epistaxis).
https://doi.org/10.1177/0194599819890327
Otolaryngology--head and Neck Surgery : Official Journal ... Tunkel DE, Anne S et. al.

Jan 8th, 2020 - Nosebleed, also known as epistaxis, is a common problem that occurs at some point in at least 60% of people in the United States. While the majority of nosebleeds are limited in severity and duration, about 6% of people who experience nosebleeds w...

see more →

Drugs  201 results see all →

Clinicaltrials.gov  112 results

Haemorrhage Risk Reduction Using Endovascular Embolisation in Place of Vessel Ligation for Patients Undergoing Transoral Robotic Surgery (HELPR)
https://clinicaltrials.gov/ct2/show/NCT05477992

Jul 28th, 2022 - The incidence of squamous cell carcinoma of oropharynx has increased at an alarming rate attributed to human papillomavirus (HPV).The prognosis of patients with HPV-associated oropharyngeal cancer is significantly improved, and as such, considerat...

The Incidence of Respiratory Symptoms Associated With the Use of HFNO
https://clinicaltrials.gov/ct2/show/NCT03619148

Jul 26th, 2022 - The study aims to evaluate what is the frequency and severity of respiratory tract symptoms following the use of high flow nasal humidified oxygen? Participants will be from 2 sub groups: Patients already undergoing TOE (as this is the most common...

Nasal Ointment on Epistaxis of Nasotracheal Intubation in Children
https://clinicaltrials.gov/ct2/show/NCT04426409

Jul 26th, 2022 - Nasotracheal intubation is one of the anesthetic procedures required for oral surgery. It allows the surgeon easier access to the surgical site than the orthotracheal intubation. Therefore, nosotracheal intubation is commonly used for general anes...

Effect of Nose Selection Using Rhnoscope on Epistaxis of Nasotracheal Intubation
https://clinicaltrials.gov/ct2/show/NCT04164836

Jul 26th, 2022 - Anterior rhinoscopy using rhinoscope is a simple way to view the intranasal structure, which allows you to observe the nasal mucosa, the inferior nasal concha, and in some cases, the nasal concha. You can see the nasal septum, polyps, and intranas...

Efficacy of Nintedanib for Treatment of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) Patients
https://clinicaltrials.gov/ct2/show/NCT04976036

Jul 26th, 2022 - Hereditary hemorrhagic telangiectasia (HHT), or Rendu-Osler-Weber disease, is a rare genetic disease with autosomal dominant transmission and a prevalence in the general population of 1/5'000 to 1/10'000. Genetic mutations in HHT affect the intrac...

see more →

News  130 results

Improving Epistaxis Knowledge and Management Among Nursing Staff
https://www.mdedge.com/jcomjournal/article/256741/hospital-medicine/improving-epistaxis-knowledge-and-management-among
Avery Nelson, MD

Aug 2nd, 2022 - From the University of Chicago Medical Center, Chicago, IL. Abstract Background: Epistaxis is a common chief complaint addressed by otolaryngologists.

Oncology Case Challenge: A Daily Beer Drinker With Bruises, Back Pain, and Bleeding
https://www.medscape.com/viewarticle/752121

Jul 28th, 2022 - Editor's Note: The Case Challenge series includes difficult-to-diagnose conditions, some of which are not frequently encountered by most clinicians but are nonetheless important to accurately recognize. Test your diagnostic and treatment skills us...

Skull Base Regeneration During Treatment With Chemoradiation for Nasopharyngeal Carcinoma: A Case Report
https://www.mdedge.com/fedprac/avaho/article/254501/head-neck/thyroid-cancers/skull-base-regeneration-during-treatment
Kelly F. Moyer, MD, Jessica H. Maxwell, MD, MPH et. al.

May 10th, 2022 - Nasopharyngeal carcinoma (NPC) differs from other head and neck (H&N) cancers in its epidemiology and treatment. Unlike other H&N cancers, NPC has a distinct geographical distribution with a much higher incidence in endemic areas, such as southern.

Ceralasertib Plus Acalabrutinib Shows Early Activity in High-Risk Relapsed/Refractory CLL
https://www.onclive.com/view/ceralasertib-plus-acalabrutinib-shows-early-activity-in-high-risk-relapsed-refractory-cll

Apr 29th, 2022 - The combination of ceralasertib (AZD6738) and acalabrutinib (Calquence) showed preliminary clinical activity with acceptable tolerability in patients with high-risk, relapsed/refractory chronic lymphocytic leukemia (CLL), according to data from a ...

FDA Grants Fast Track Status to HPN217 for Relapsed/Refractory Multiple Myeloma
https://www.onclive.com/view/fda-grants-fast-track-status-to-hpn217-for-relapsed-refractory-multiple-myeloma

Mar 3rd, 2022 - The FDA has granted a fast track designation to the BCMA-targeting Tri-specific T-cell Activating Construct (TriTAC), HPN217, for use as a potential therapeutic option in patients with relapsed or refractory multiple myeloma who have previously re...

see more →

Patient Education  1 results see all →